These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8035616)

  • 21. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
    Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R
    Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
    Zwaan CM; Kaspers GJ; Pieters R; Ramakers-Van Woerden NL; den Boer ML; Wünsche R; Rottier MM; Hählen K; van Wering ER; Janka-Schaub GE; Creutzig U; Veerman AJ
    Blood; 2000 Oct; 96(8):2879-86. PubMed ID: 11023525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
    Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
    Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in china.
    Tong H; Wang Q; Lu C; Liu Z; Hu Y
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):437-41. PubMed ID: 21792039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
    Lönnerholm G; Thörn I; Sundström C; Frost BM; Flaegstad T; Heyman M; Jonsson OG; Harila-Saari A; Madsen HO; Porwit A; Schmiegelow K; Söderhäll S; Wesenberg F; Vettenranta K; Larsson R; Forestier E
    Leuk Res; 2011 Apr; 35(4):472-8. PubMed ID: 20961616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
    Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
    Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Kumagai M; Manabe A; Coustan-Smith E; Blakley RL; Beck WT; Santana VM; Behm FG; Raimondi SC; Campana D
    Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.
    Pogorzala M; Kubicka M; Rafinska B; Wysocki M; Styczynski J
    Anticancer Res; 2015 Oct; 35(10):5667-70. PubMed ID: 26408741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
    Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
    Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
    Campana D; Manabe A; Evans WE
    Leukemia; 1993 Mar; 7(3):482-8. PubMed ID: 7680404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Veerman AJ
    Leuk Lymphoma; 1995 Nov; 19(5-6):407-16. PubMed ID: 8590840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Response to treatment and survival of adults with acute leukemia classified with immunophenotyping and cytochemistry].
    Sobrevilla Calvo P; Acosta Barreda A; López Karpóvitch X; Salles Manuel MT; Reynoso Gómez E; Guarner Lans J
    Rev Invest Clin; 1994; 46(5):399-406. PubMed ID: 7839021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Leukemia in childhood].
    Masera G; Adamoli L; Conter V; Piacentini G
    Pediatr Med Chir; 1988; 10(2):133-41. PubMed ID: 3050901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
    Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
    Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing.
    Hongo T; Okada S; Inoue N; Yamada S; Yajima S; Watanabe C; Fujii Y; Horikoshi Y
    Int J Hematol; 2002 Oct; 76(3):251-9. PubMed ID: 12416736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.